Containment Level 3 Platform

 

Research Institute of the McGill University Health Centre Containment Level 3 (CL3) Technology Platform  

 

The Containment Level 3 (CL3) Platform has three independent research pods that meet the highest safety standards defined by Canadian Biosafety Standards and Guidelines (PHAC). The facility is available to RIMUHC researchers, affiliated collaborators and external researchers whose work requires a facility where trained users can manipulate various pathogenic organisms (Mycobacterium tuberculosis, SARS-CoV-2). Users of the CL3 Platform must follow the established Standard Operating Procedures (SOPs) as defined in the Platform’s SOP manual.

 

POD1 CL3 facility: Two laboratories (Mycobacterium tuberculosis) and an animal holding room.  

POD 2 CL3 facility: One laboratory (SARS-CoV-2) and an animal holding room

POD3 TBD: Two laboratories

 

The RI MUHC CL3 Technology Platform must adhere strictly to the standard operating procedures; once a set of investigations is approved, the facility manager will oversee training, provide guidance to researchers and monitoring of experiments.

For further information on the RI MUHC CL3 TB Platform, please contact Fiona McIntosh, Platform Manager, at 514-887-4343

 

Access Guidelines:

 

For all new projects requiring the use of the CL3 Platform facilities, investigators must complete the Application to Use Biohazardous Materials form and submit this document to Environmental Health and Safety (EHS) via email (ri.ehs@muhc.mcgill.ca) for review and approval. EHS will determine if the project requires access to the CL3 Platform. The CL3 Platform will grant access based on space and resource availability. The assigned POD supervisor will provide appropriate training. Note: Due to this reorganization, current and past users may need to amend their Biohazardous Materials form with updated protocols. They may also be required to take “refresher” training to ensure SOPs used in the Platform are of a high standard and are consistent with PHAC guidelines. 

 

• Users must have a CrossLabs account. Sign up for a new account using the link in the upper right-hand corner, or click here. For help with the registration process, follow the how-to instructions here. Need a password? Reset your password here.

 

• All applicants must complete all of the pre-training requirements before initiating training in the CL3 Technology Platform. These requirements are listed under the Training Request Tab.

   

• Visit the Customer Help Manual for further guidance using CrossLabs Core Facility Services.

 

Management:

 

Director: 

 

Dr. Andréanne Lupien

Research Institute of the McGill University Health Centre

1001 Blvd. Decarie, Room EM3 3238

Montreal QC, H4A 3J1

Phone: 514-438-522-4879

 

email: andreanne.lupien@mcgill.ca

 

     

 

           

Manager:  

   

Fiona McIntosh
Research Institute of the McGill University Health Centre

1001 Blvd. Decarie, Room EM3-3211

Montreal QC, H4A 3J1

phone: 514-887-4343

Supervisors:  

 

   POD1 (TB-CL3): TBD

   POD2 (SARS-CoV-2-CL3): TBD

   POD3: TBD

 

 

Location and hours of operation

 

Hours	Location
Always open	1001 Blvd. Decarie ES2-6000 Montreal QC H4A 3J1

Links and Resources

 

Containment Level 3 at the MUHC Research Institute

RIMUHC Technology Platforms website 

Canadian Biosafety Standards and Guidelines